U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H12N2S2.ClH
Molecular Weight 188.742
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Cystamine hydrochloride

SMILES

Cl.NCCSSCCN

InChI

InChIKey=NULDEVQACXJZLL-UHFFFAOYSA-N
InChI=1S/C4H12N2S2.ClH/c5-1-3-7-8-4-2-6;/h1-6H2;1H

HIDE SMILES / InChI

Molecular Formula C4H12N2S2
Molecular Weight 152.281
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Targets
PubMed

PubMed

TitleDatePubMed
Molecular recognition of avidin on biotin-functionalized gold surfaces detected by FT-IRRAS and use of metal carbonyl probes.
2002 Jan 1
Radioprotective effects of amifostine (WR-2721) or cystamine on radiation damage and its repair in rats whole body exposed to fission neutrons.
2004
Transglutaminases - possible drug targets in human diseases.
2004 Apr
Dependence of Giardia lamblia encystation on novel transglutaminase activity.
2004 Aug
Arabidopsis thaliana glutamate-cysteine ligase: functional properties, kinetic mechanism, and regulation of activity.
2004 Aug 6
Isolation and functional characterization of a cyst(e)amine-sensitive protein protecting methyl-dithio groups.
2004 Dec
Interrelationships among microbiological, physicochemical, and biochemical properties of Terrincho cheese, with emphasis on biogenic amines.
2004 Dec
Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine.
2004 Dec 31
Effects of naringin on cytosine arabinoside (Ara-C)-induced cytotoxicity and apoptosis in P388 cells.
2004 Jun 4
Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase.
2004 Jun 4
Synthesis, structure and electrochemistry of ferrocene-peptide macrocycles.
2004 Jun 7
Protective role of tissue transglutaminase in the cell death induced by TNF-alpha in SH-SY5Y neuroblastoma cells.
2004 Mar 31
Accumulation of phenyl boronic acid-carrying telomers on a gold surface.
2004 May 1
Asialoerythropoietin is not effective in the R6/2 line of Huntington's disease mice.
2004 May 10
Fishing of beta-amylase with a SAM of alpha-cyclodextrin-poly- (ethylene glycol) conjugate.
2004 Nov 15
Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.
2004 Oct
Amperometric cholesterol biosensor based on in situ reconstituted cholesterol oxidase on an immobilized monolayer of flavin adenine dinucleotide cofactor.
2004 Oct 1
Production of dromedary (Camelus dromedarius) embryos by IVM and IVF and co-culture with oviductal or granulosa cells.
2004 Oct 1
Cell-based assay for monitoring transglutaminase activity.
2004 Oct 15
The influence of methylene blue on the spontaneous contractity of the non-pregnant human myometrium and on the myometrial response to DEA/NO.
2005
Poly(ethylene oxide)-b-poly(N-isopropylacrylamide) nanoparticles with cross-linked cores as drug carriers.
2005
Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent.
2005 Apr
Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease.
2005 Apr 15
Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease.
2005 Aug
Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.
2005 Aug
[Lorentz Eldjarn--a catalyst for chemistry in Norwegian medicine].
2005 Dec 15
Characterization of purified rat testicular transglutaminase and age-dependent changes of the enzyme activities.
2005 Feb
Resistance of zwitterionic telomers accumulated on metal surfaces against nonspecific adsorption of proteins.
2005 Feb 15
Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3.
2005 Jan
Formulation and surface modification of poly(ester-anhydride) micro- and nanospheres.
2005 Jan
Small artery remodeling depends on tissue-type transglutaminase.
2005 Jan 7
Mechanism for the inhibition of transglutaminase 2 by cystamine.
2005 Mar 15
Glutathione synthesis in Streptococcus agalactiae. One protein accounts for gamma-glutamylcysteine synthetase and glutathione synthetase activities.
2005 Mar 25
Post-translational disulfide modifications in cell signaling--role of inter-protein, intra-protein, S-glutathionyl, and S-cysteaminyl disulfide modifications in signal transmission.
2005 May
Determination of total cysteamine in human plasma in the form of its 2-S-quinolinium derivative by high performance liquid chromatography.
2005 May
Construction of a tethered poly(ethylene glycol) surface gradient for studies of cell adhesion kinetics.
2005 May 24
A general fluorescence-based coupled assay for S-adenosylmethionine-dependent methyltransferases.
2005 May 27
Identification of an inactivating cysteine switch in protein kinase Cepsilon, a rational target for the design of protein kinase Cepsilon-inhibitory cancer therapeutics.
2005 Nov 15
Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease.
2005 Oct
A novel small molecule CFTR inhibitor attenuates HCO3- secretion and duodenal ulcer formation in rats.
2005 Oct
Covalent attachment of glucose oxidase to an Au electrode modified with gold nanoparticles for use as glucose biosensor.
2005 Sep
Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.
2006 Apr
CYTE-I-HD: phase I dose finding and tolerability study of cysteamine (Cystagon) in Huntington's disease.
2006 Apr
Mechanistic insight provided by glutaredoxin within a fusion to redox-sensitive yellow fluorescent protein.
2006 Feb 21
The p53 oncoprotein is a substrate for tissue transglutaminase kinase activity.
2006 Jan 13
Neuroprotective effects of cystamine in aged parkinsonian mice.
2006 Jun
The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase.
2006 Jun
Stepwise assembly of acceptor--sigma spacer--donor monolayers: preparation and electrochemical characterization.
2006 Mar 28
Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population.
2006 Oct
Capillary electrophoresis method development for determination of impurities in sodium cysteamine phosphate samples.
2006 Sep 11
Patents

Patents

Substance Class Chemical
Created
by admin
on Sat Dec 16 19:53:43 GMT 2023
Edited
by admin
on Sat Dec 16 19:53:43 GMT 2023
Record UNII
C2U867X2F7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Cystamine hydrochloride
Common Name English
NSC-613802
Code English
2-[(2-Aminoethyl)disulfanyl]ethan-1-amine hydrochloride
Systematic Name English
Ethanamine, 2,2′-dithiobis-, hydrochloride (1:1)
Systematic Name English
Code System Code Type Description
PUBCHEM
167628
Created by admin on Sat Dec 16 19:53:43 GMT 2023 , Edited by admin on Sat Dec 16 19:53:43 GMT 2023
PRIMARY
NSC
613802
Created by admin on Sat Dec 16 19:53:43 GMT 2023 , Edited by admin on Sat Dec 16 19:53:43 GMT 2023
PRIMARY
FDA UNII
C2U867X2F7
Created by admin on Sat Dec 16 19:53:43 GMT 2023 , Edited by admin on Sat Dec 16 19:53:43 GMT 2023
PRIMARY
CAS
1072-22-6
Created by admin on Sat Dec 16 19:53:43 GMT 2023 , Edited by admin on Sat Dec 16 19:53:43 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE